CII in close partnership with the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India organized the “12th National Pharmaceutical Conclave: Make, Develop and Innovate in India” on 12-13 December, 2014 at New Delhi.
The conclave enabled multiple stakeholders to discuss and deliberate on changes that are considered necessary for unlocking the true potential of the Indian pharmaceutical industry.
The conclave further helped in identifying various issues as well as some possible solutions through seven dedicated plenary sessions:
- Positioning India as a high quality global manufacturing hub for the pharmaceutical sector
- Creating a stable business environment through a responsive regulatory framework
- IPR Issues and its impact on drug development
- Accessibility to healthcare – balancing social considerations with industry growth
- Creating a research ecosystem conducive to innovations in drug discovery and development
- Capacity building in pharmaceuticals via innovative PPP Models
- API industry struggling to sustain its competitive edge
A structured approach was followed to help prioritise the deliberations presented at the conclave.
The document essentially aims to capture the key observations in each of the sessions, present some ideas on possible actions which promise the highest favourable impact on the industry and identify key stakeholder groups which would then help chart the next steps through further deliberations.